Tag: Pfizer

Pfizer’s potent antiviral treatment endorsed by WHO

April 22, 2022

The World Health Organization (WHO) has backed the use of Pfizer Inc’s (Pfizer) oral COVID-19 antiviral treatment, Paxlovid, in high-risk patients in the early stages of the disease, to avoid hospitalisation. However, WHO is quick to mention that existing COVID-19 treatments including intravenous and antibody treatments, are not to replace vaccination. The recommendation by WHO […]

Continue Reading

FDA approves booster dose of Pfizer COVID-19 vaccine for US citizens

September 24, 2021

This week, the US Food and Drug Administration (FDA) approved of a booster shot for the Pfizer-BioNTech (Pfizer) COVID-19 vaccine for at-risk individuals in the US. The FDA has amended the prior emergency use authorisation for Pfizer’s COVID-19 vaccine to now include a third booster dose to be given at least six months after the […]

Continue Reading

Pfizer’s COVID-19 vaccine now stable at warmer temperatures

February 23, 2021

The mRNA COVID-19 vaccine developed by pharmaceutical companies Pfizer and BioNTech late last year was advised to be kept at ultra-cold temperatures to prevent degradation – the ultra-cold storage requirement has inevitably been a difficult and expensive problem to overcome in many parts of the world. However, new company data from Pfizer suggests its vaccine […]

Continue Reading

First shipment of COVID-19 vaccine arrives in Malaysia

February 22, 2021

The first batch of the Pfizer-BioNTech COVID-19  vaccine arrived in Malaysia on Sunday – 312,390 doses that were flown to Kuala Lumpur International Airport (KLIA) in Sepang are part of a total of 32 million doses Malaysia is procuring from US pharmaceutical giant Pfizer Inc to battle the pandemic. The next batch is scheduled to […]

Continue Reading

Phl OK’s use of Pfizer Covid-19 vaccine; detects first new virus variant case in Manila

January 15, 2021

The Philippines has given the green light to Pfizer BioNTech’s Covid-19 vaccine for emergency use. According to Food and Drug Administration (FDA) Director-General Eric Domingo, the authorization was granted after a thorough review of currently available data by medical and regulatory experts.   The Pfizer BioNTech Covid-19 vaccine, which based on Phase III trials data, has […]

Continue Reading

Pfizer/BioNTech first in WHO list for emergency use COVID-19 vaccine

January 5, 2021

The World Health Organization (WHO) has listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago. Dr Mariângela Simão, WHO Assistant-Director General for Access to Medicines and Health Products hails it as “a very positive step towards […]

Continue Reading